These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6797459)

  • 21. Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time.
    Aihara M; Kimura A; Chiba Y; Yoshida Y
    Thromb Haemost; 1988 Jun; 59(3):485-90. PubMed ID: 3142084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular characterization of quinine/quinidine drug-dependent antibody platelet interaction using monoclonal antibodies.
    Berndt MC; Chong BH; Bull HA; Zola H; Castaldi PA
    Blood; 1985 Dec; 66(6):1292-301. PubMed ID: 3904869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An immunoradiometric assay for human factor VIII/von Willebrand factor (VIII:vWF) using a monoclonal antibody that defines a functional epitope.
    Goodall AH; Jarvis J; Chand S; Rawlings E; O'Brien DP; McGraw A; Hutton R; Tuddenham EG
    Br J Haematol; 1985 Apr; 59(4):565-77. PubMed ID: 2580547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factor VIII/von Willebrand factor in subendothelium mediates platelet adhesion.
    Turitto VT; Weiss HJ; Zimmerman TS; Sussman II
    Blood; 1985 Apr; 65(4):823-31. PubMed ID: 3872140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional domains on von Willebrand factor. Recognition of discrete tryptic fragments by monoclonal antibodies that inhibit interaction of von Willebrand factor with platelets and with collagen.
    Sixma JJ; Sakariassen KS; Stel HV; Houdijk WP; In der Maur DW; Hamer RJ; de Groot PG; van Mourik JA
    J Clin Invest; 1984 Sep; 74(3):736-44. PubMed ID: 6332119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa.
    Coller BS; Peerschke EI; Scudder LE; Sullivan CA
    J Clin Invest; 1983 Jul; 72(1):325-38. PubMed ID: 6308050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycoprotein Ib has a partial role in platelet-von Willebrand factor collagen interaction.
    Aihara M; Tamura K; Kawarada R; Okawa K; Yoshida Y
    Thromb Haemost; 1988 Oct; 60(2):182-7. PubMed ID: 3064358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adhesion of blood platelets to human arterial subendothelium: role of factor VIII-Von Willebrand factor.
    Bolhuis PA; Sakariassen KS; Sixma JJ
    Haemostasis; 1979; 8(3-5):312-23. PubMed ID: 315905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoclonal antibodies to platelet glycoproteins Ib and IIb/IIIa inhibit adhesion of platelets to purified solid-phase von Willebrand factor.
    Danton MC; Zaleski A; Nichols WL; Olson JD
    J Lab Clin Med; 1994 Aug; 124(2):274-82. PubMed ID: 8051492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of purified type IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation.
    De Marco L; Girolami A; Zimmerman TS; Ruggeri ZM
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7424-8. PubMed ID: 2932740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship of the properties of antihemophilic factor (factor VIII) that support ristocetin-induced platelet agglutination (factor VIIIR:RC) and platelet retention by glass beads as demonstrated by a monoclonal antibody.
    Ogata K; Saito H; Ratnoff OD
    Blood; 1983 Jan; 61(1):27-35. PubMed ID: 6401215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Asialo von Willebrand factor enhances platelet adhesion to vessel subendothelium.
    Bastida E; Monteagudo J; Ordinas A; De Marco L; Castillo R
    Thromb Haemost; 1988 Aug; 60(1):30-4. PubMed ID: 3263711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies against platelet membrane glycoproteins. III. Effect on thrombin-and bovine Von Willebrand factor-induced aggregation.
    Jenkins CS; Clemetson KJ; Ali-Briggs EF
    Br J Haematol; 1983 Mar; 53(3):491-501. PubMed ID: 6600621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of von Willebrand factor-induced platelet agglutination by ADP does not result from reduced binding of total von Willebrand factor or its larger multimers.
    Zucker MB; Puszkin EG; Sussman II; Mauss EA
    J Lab Clin Med; 1990 Sep; 116(3):305-14. PubMed ID: 2401846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Localization of von Willebrand factor and thrombin-interactive domains on human platelet glycoprotein Ib.
    Katagiri Y; Hayashi Y; Yamamoto K; Tanoue K; Kosaki G; Yamazaki H
    Thromb Haemost; 1990 Feb; 63(1):122-6. PubMed ID: 2339348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of murine anti-glycoprotein Ib monoclonal antibodies that differentiate between shear-induced and ristocetin/botrocetin-induced glycoprotein Ib-von Willebrand factor interaction.
    Cauwenberghs N; Ajzenberg N; Vauterin S; Hoylaerts MF; Declerck PJ; Baruch D; Deckmyn H
    Haemostasis; 2000; 30(3):139-48. PubMed ID: 11014964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibodies against human factor VIII molecular neutralize antihemophilic factor and ristocetin cofactor activities.
    Sola B; Avner P; Sultan Y; Jeanneau C; Maisonneuve P
    Proc Natl Acad Sci U S A; 1982 Jan; 79(1):183-7. PubMed ID: 6798569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.
    Kageyama S; Yamamoto H; Nagano M; Arisaka H; Kayahara T; Yoshimoto R
    Br J Pharmacol; 1997 Sep; 122(1):165-71. PubMed ID: 9298543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence that the primary binding site of von Willebrand factor that mediates platelet adhesion on subendothelium is not collagen.
    de Groot PG; Ottenhof-Rovers M; van Mourik JA; Sixma JJ
    J Clin Invest; 1988 Jul; 82(1):65-73. PubMed ID: 2839553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.